Recombinant PEG 抗体 (methoxylated)
Quick Overview for Recombinant PEG 抗体 (methoxylated) (ABIN2830995)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- methoxylated
-
特异性
- This antibody reacts to lysine-acetylated proteins.
-
交叉反应 (详细)
- No cross reactivity with nonacetylated lysine, and lysine with other modification.
-
纯化方法
- Protein A affinity purified from an animal origin-free culture supernatant
-
免疫原
- KLH-PEG with terminal methoxy group
-
亚型
- IgG
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 mg/mL
-
缓冲液
- PBS with 1 % BSA and 0.09 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
有效期
- 12-24 months
-
-
-
Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma." in: Oncogenesis, Vol. 8, Issue 3, pp. 18, (2019) (PubMed).
: "Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts." in: Respiratory research, Vol. 18, Issue 1, pp. 80, (2018) (PubMed).
: "Inhibition of ornithine decarboxylase 1 facilitates pegylated arginase treatment in lung adenocarcinoma xenograft models." in: Oncology reports, Vol. 40, Issue 4, pp. 1994-2004, (2018) (PubMed).
: "Recombinant human arginase induces apoptosis through oxidative stress and cell cycle arrest in small cell lung cancer." in: Cancer science, Vol. 109, Issue 11, pp. 3471-3482, (2018) (PubMed).
: "Cross-Reactivity of Select PEG-Binding Antibodies to Other Polymers Containing a C-C-O Backbone." in: ACS biomaterials science & engineering, Vol. 3, Issue 8, pp. 1605-1615, (2017) (PubMed).
: "
-
Endogenous arginase 2 as a potential biomarker for PEGylated arginase 1 treatment in xenograft models of squamous cell lung carcinoma." in: Oncogenesis, Vol. 8, Issue 3, pp. 18, (2019) (PubMed).
-
- PEG (Polyethylene Glycol (PEG))
-
别名
- PEG (Methoxy Group)
抗原
-